Skip to main content Help with accessibility Skip to main navigation

Paliperidone palmitate prolonged release suspension for injection (six monthly)

Indication

Treatment of schizophrenia in adult patients who are clinically stable on 1-monthly or 3-monthly paliperidone palmitate injectable products

Grey

Brand:

Byannli

Nice TA:

Commissioning responsibility:

CCG (HRG included)

PbR excluded:

No

BNF chapter:
Central nervous system

Background

Recommendation

LSCMMG Recommendation:

Grey

Reason for decision:

Prioritised for review

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
What do the colours mean?

Last Updated: 19 - Apr - 2022